Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Total Debt (2020 - 2021)

Historic Total Debt for Burning Rock Biotech (BNR) over the last 3 years, with Q3 2025 value amounting to $253000.0.

  • Burning Rock Biotech's Total Debt changed N/A to $253000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $253000.0, marking a year-over-year change of. This contributed to the annual value of $372000.0 for FY2021, which is 9300.36% down from last year.
  • According to the latest figures from Q3 2025, Burning Rock Biotech's Total Debt is $253000.0.
  • Burning Rock Biotech's 5-year Total Debt high stood at $5.0 million for Q1 2021, and its period low was $253000.0 during Q3 2025.